StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
123330.KQ$22900.00+0.66%
Fair $22900.00+0.0%

123330.KQ

Genic Co., Ltd.

Consumer Defensive / Household & Personal ProductsKOSDAQ

$22900.00

+150.00 (+0.66%)

Fairly Valued+0.0%Fair Value $22900.00Fund rank 27/100 · Data gapFallback financials|
SA 50/C
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-1.1B · quality 47.7/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 17/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 123330.KQLocal privado en este navegador · Genic Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$179.2B

P/E

9.5x

↓

EV/EBITDA

9.9x

↑

ROE

46.0%

↑

Gross Margin

28.8%

↑

Debt/Equity

0.07

↓
52-Week Range$22900
$15570$44100

TradingView lightweight chart

123330.KQ price, volumen y niveles de valoración

Último $22,900Periodo -20.7%
Fair value: $22,900

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+35.5%

FCF CAGR

—

FCF margin

23.0%

FCF / Net income

0.95x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $78.20B · net income $18.89B · FCF $17.97B

2022-FY → 2025-FY

Gross margin

28.8%+20.2% pts

Operating margin

19.2%+28.2% pts

Net margin

24.2%+34.8% pts

FCF margin

23.0%+26.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$78.20B$78.20B$49.91B$28.07B$31.45B
Net Income$18.89B$18.89B$7.56B$-4.41B$-3.34B
EBITDA$17.11B$17.11B$7.73B$-2.20B$-979.1M
EPS2414.002414.001036.00-643.00-487.00
Gross Margin28.8%28.8%23.3%11.5%8.6%
Operating Margin19.2%19.2%12.1%-14.3%-9.1%
Net Margin24.2%24.2%15.2%-15.7%-10.6%
Balance Sheet
Debt/Equity0.070.070.270.630.69
Current Ratio1.951.95———
Cash Flow
Free Cash Flow$17.97B$17.97B$-1.38B$-1.11B$-1.24B
Returns
ROE46.0%46.0%34.1%-38.2%-20.9%
Valuation
P/E9.499.4924.18——
EV/EBITDA9.859.8524.25——
P/B4.364.368.252.171.95
Growth & Yield
Revenue Growth56.7%56.7%77.8%-10.7%—
EPS Growth133.0%133.0%261.1%-32.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-5.6%

fácil

EPS terminal req.

$2031.99

Spread vs growth

138.6%

5Y implied EPS CAGR

0.4%

fácil

EPS terminal req.

$2458.71

Spread vs growth

132.6%

10Y implied EPS CAGR

5.1%

razonable

EPS terminal req.

$3959.78

Spread vs growth

127.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -9.8%

Total return

-9.8%

Start / end P/E

24.5x → 9.5x

EPS bridge

1036.00 → 2414.00

Residual

-81.5%

EPS growth+133.0%
Multiple rerating-61.3%
Dividend+0.0%
Residual / FX / buybacks / cross-term-81.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.